We are thrilled to share the exciting news that OncoSwab has been selected to participate in the prestigious Venture Kick program, securing funding of 10,000 CHF and support to bring our innovative solution one step closer to reality.
Venture Kick is an internationally recognized program dedicated to supporting innovative startups, especially those emerging from Swiss universities. In addition to providing funding, Venture Kick offers access to a valuable network of investors and industry experts, helping to accelerate the growth and success of startups.
🚀 OncoSwab's achievement in Venture Kick 🚀
Our revolutionary approach to lung cancer screening, using nasal fluid collection and cutting-edge technology, has captured the attention of Venture Kick and propels us forward on our path to early and accessible lung cancer detection.
The point-of-care test developed by OncoSwab has the potential to revolutionize lung cancer diagnosis. By eliminating the traditional barriers associated with current screening methods, such as accessibility and the need for specialized medical personnel, our solution offers a non-invasive, fast, and cost-effective alternative for early lung cancer detection.
Join us on our exciting journey as we work to transform lung cancer detection with OncoSwab. Stay tuned for the latest updates and advancements as we progress with Venture Kick and strive to make a significant difference in the fight against lung cancer.